Health | infostain

Guide to Orthodontic Treatment for Healthier Dental Alignment

Orthodontics is a specialized area of dentistry concerned with the position of teeth and the relationship between the upper and lower jaws. An orthodontist evaluates dental alignment and bite . . .

Insights on Ingrezza Usage Interactions and Safety

Ingrezza contains valbenazine and is taken orally. Its use depends on the condition being treated and the individual treatment plan. The FDA prescribing information identifies specific interactions and precautions . . .

Explore Important Facts About Ingrezza Medication

Ingrezza, or valbenazine, is a vesicular monoamine transporter 2 inhibitor used to manage certain involuntary movement disorders in adults. The U.S. Food and Drug Administration lists it for treating . . .

Read About Valbenazine Uses and General Medication Information

Valbenazine is an oral medication that belongs to the VMAT2 inhibitor class. It is approved for adults with tardive dyskinesia and for adults with chorea associated with Huntington disease. . . .

Guide to Understanding Ingrezza Side Effects and Precautions

Ingrezza, whose active ingredient is valbenazine, is a prescription medicine used to treat certain movement disorders, including tardive dyskinesia and chorea associated with Huntington’s disease. Understanding possible side effects . . .

Learn About Ingrezza and Huntington Disease Chorea Treatment

Huntington disease is a hereditary neurodegenerative disorder that can affect movement, thinking, mood, and behavior. Chorea is one of its commonly recognized movement symptoms and involves involuntary, irregular, and . . .

Insights on Ingrezza for Tardive Dyskinesia

Ingrezza, whose active ingredient is valbenazine, is an FDA approved medicine for adults with tardive dyskinesia. Tardive dyskinesia can cause persistent, involuntary movements involving the face, mouth, tongue, limbs, . . .

Explore Ingrezza Valbenazine and Its Role in Movement Disorders

Movement disorders can cause involuntary or poorly controlled movements that affect daily activities and quality of life. Ingrezza, whose active ingredient is valbenazine, is a vesicular monoamine transporter 2 . . .

Read About Ingrezza Dosage and Important Safety Information

Ingrezza contains valbenazine and belongs to a group of medicines called vesicular monoamine transporter 2 inhibitors. The U.S. prescribing information indicates its use for adults with tardive dyskinesia or . . .

Guide to Ingrezza Medication and Its Common Uses

Ingrezza, also known by its generic name valbenazine, is an oral medication classified as a vesicular monoamine transporter 2 or VMAT2 inhibitor. The United States Food and Drug Administration . . .